Ginsenoside Rg1 alleviates dehydroepiandrosterone-induced polycystic ovary syndrome by regulating granulosa cell glycolysis, proliferative activity, and apoptosis through the PI3K/Akt/mTOR pathway.
Polycystic ovary syndrome (PCOS) represents a common endocrine-metabolic disorder. Mounting evidence has demonstrated that Korean red ginseng confers therapeutic advantages in PCOS; accordingly, this investigation sought to elucidate the therapeutic potential of its bioactive constituent, ginsenoside Rg1, in this patho...